CPI

Biologics manufacturing needs to do more with less, and the answer is process intensification. As pressure grows to boost productivity, cut costs and reduce environmental impact, we're here to help manufacturers intensify upstream and downstream processes with confidence. Test, validate and de-risk smarter manufacturing approaches before major CAPEX decisions. ⬇️ Request a free process intensification diagnostic with our experts.

Smarter, Faster & More Sustainable Biologics Manufacturing Starts Here For SME biotechs, scaling biologics can mean tough trade-offs: ➡️ invest early and risk getting it wrong ➡️ wait too long and lose time, funding or momentum CPI’s Process Intensification offer helps SMEs test, validate and de-risk smarter manufacturing approaches before major CAPEX decisions. We work with you to: ✅ Generate decision-ready data quickly ✅ Improve yield, productivity and sustainability ✅ Reduce facility footprint and operating costs ✅ Build confidence for scale-up, tech transfer or investor discussions Our vendor-neutral facilities and expert teams support programmes across mAbs and emerging biologics, which helps SMEs move faster, with lower technical and commercial risk. ⬇️ Request a free process intensification diagnostic with our experts.

Ready to scale? CPI's got your back, and breakthrough 🚀 From concept to commercial scale, with state-of-the-art facilities and expertise, we’re here to help innovators overcome barriers, de-risk development and get products to market faster. Our refreshed market pages show exactly how we can support innovation across: 🩺 MedTech: turning medical ideas into devices that change lives. 🧬 Pharma: accelerating sustainable drug development and manufacture. 🧫 Bioprocess scale-up: scaling biotechnologies for real-world impact. ♻️ Sustainable materials: advancing sustainable materials and battery technologies. Becky Fields will tell you more. Let's innovate together ⬇️ Learn how CPI can accelerate your route to commercialisation ➡️ https://lnkd.in/eTAr_5bG Asif Tulah Melanie Geer Jude Huggan Alex Cole Anthony Celli #ScaleUp | #MedTech | #Pharma #LetsInnovateTogether | #Innovation | #Materials

Lab capability alone does not guarantee industrial scalability. CPI gives sustainable materials teams access to process expertise and scale-up infrastructure, helping you validate processes at industrially relevant scales.

Promising lab results still need evidence of viability. CPI helps you build LCA and TEA evidence, reduce scale-up uncertainty and strengthen decisions around environmental and commercial viability.